Product Information
CEPHALEXIN 500 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.1200 per EA under NDC 00904733706. Its NADAC has been published 133 times since Mar 20, 2024.
FDA first approved this application on Dec 20, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904733706
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CEPHALEXINApproval Type
Generic (ANDA)
FDA Application
ANDA090836FDA Approved
12/20/2010
TE Code
AB
On Market Since
11/6/2023
Pharmacological Classes
Price Statistics
The NADAC for CEPHALEXIN 500 MG CAPSULE has been published 133 times since Mar 20, 2024, and over the history we have for it it has declined 17.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1200 per EA |
|---|---|
| All-time high | $0.1460 (Apr 10, 2024) |
| All-time low | $0.0897 (Nov 20, 2024) |
| 52-week high | $0.1281 |
| 52-week low | $0.1200 |
| Median price | $0.1241 |
| Average price | $0.1237 |
| Largest weekly change | -30.2% (Nov 20, 2024) |
| Weeks tracked | 133 |
| Tracking since | Mar 20, 2024 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cephalexin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEPHALEXIN 500 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEPHALEXIN 500 MG CAPSULE, manufactured by Major Pharmaceuticals, is $0.1200 per EA (NDC 00904733706), effective Sep 30, 2026.
How has the price of CEPHALEXIN 500 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEPHALEXIN 500 MG CAPSULE has declined 17.8%. It has been tracked across 133 weekly CMS publications since Mar 20, 2024.
What are the highest and lowest recorded NADAC prices for CEPHALEXIN 500 MG CAPSULE?
Since Mar 20, 2024, the NADAC for CEPHALEXIN 500 MG CAPSULE has ranged from a low of $0.0897 (Nov 20, 2024) to a high of $0.1460 (Apr 10, 2024), with a median of $0.1241 per EA.
Are there cheaper alternatives to CEPHALEXIN 500 MG CAPSULE?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEPHALEXIN 500 MG CAPSULE, is $0.0924 per EA — about 23% below CEPHALEXIN 500 MG CAPSULE.
Who manufactures CEPHALEXIN 500 MG CAPSULE?
CEPHALEXIN 500 MG CAPSULE (NDC 00904733706) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.